SCHEMBL19264396

SCHEMBL19264396

Cc1ccc(S(=O)(=O)OC[C@H]2C[C@H](c3nc(-c4ccc5ccc(-c6ccccc6)nc5c4)c4c(N)cccn43)C2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IGF1R P08069 19/20 0.55
CYP3A4 P08684 9/20 0.55
INSR P06213 5/20 0.52
KDR P35968 2/20 0.52
EGFR P00533 1/20 0.52
MAPK3 P27361 2/20 0.49
MAPK1 P28482 2/20 0.49
MAPK6 Q16659 1/20 0.49
RIPK2 O43353 1/20 0.48
ROCK2 O75116 1/20 0.48
LATS1 O95835 1/20 0.48
LCK P06239 1/20 0.48
LYN P07948 1/20 0.48
RET P07949 1/20 0.48
ABCB1 P08183 1/20 0.48
MET P08581 1/20 0.48
FGFR1 P11362 1/20 0.48
INSRR P14616 1/20 0.48
FECH P22830 1/20 0.48
MARK3 P27448 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19264209 0.90 IGF1R (0.69) IGF1RCYP3A4INSRKDREGFR
SCHEMBL400704 0.90 IGF1R (0.69) IGF1RCYP3A4INSRKDREGFR
SCHEMBL399836 0.90 IGF1R (0.69) IGF1RCYP3A4INSRKDREGFR
SCHEMBL398880 0.90 IGF1R (0.69) IGF1RCYP3A4INSRKDREGFR
SCHEMBL10225944 0.84 IGF1R (0.66) IGF1RCYP3A4INSRKDREGFR
SCHEMBL3895765 0.80 IGF1R (0.54) IGF1RCYP3A4INSRKDREGFR
SCHEMBL14031994 0.80 IGF1R (0.60) IGF1RCYP3A4INSRKDREGFR
SCHEMBL27678737 0.79 IGF1R (0.67) IGF1RCYP3A4INSRKDREGFR
SCHEMBL14031805 0.79 IGF1R (0.62) IGF1RCYP3A4INSRKDREGFR
SCHEMBL13448156 0.79 IGF1R (0.68) IGF1RCYP3A4INSRKDREGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2168968-B1 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors OSI PHARMACEUTICALS LLC (US) 2017-08-23 EP disclosed